This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Clorox (CLX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 17.34% and 4.30%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Estee Lauder (EL) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Soft store traffic stemming from coronavirus-induced restrictions on travel and consumer health concerns are likely to get reflected in Estee Lauder's (EL) second-quarter fiscal 2021 performance.
Is Clorox (CLX) Likely to Report a Beat in Q2 Earnings?
by Zacks Equity Research
Clorox's (CLX) Q2 performance is likely to have benefited from the pandemic-led cleaning frenzy among consumers, which has led to escalated demand for cleaning products.
Clorox (CLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Up More Than 23% in a Year: What You Should Know
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy, which targets boosting overall growth, bodes well. Notably, the company's cost-savings program is significantly contributing to gross margin expansion.
Clorox (CLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $197.84, moving +0.72% from the previous trading session.
Why Clorox (CLX) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Clorox (CLX) Stock Moves -0.35%: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $202.45, moving -0.35% from the previous trading session.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $202.38 in the latest trading session, marking a +0.22% move from the prior day.
Clorox (CLX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $200.51 in the latest trading session, marking a -1.17% move from the prior day.
5 Soaps & Cleaning Products Stocks Worth a Look Amid Coronavirus Woes
by Vidya Nair
The COVID-led rising demand for hygiene products is a boon for several soap and cleaning materials companies such as Procter & Gamble (PG), Unilever (UL), Colgate (CL), Clorox (CLX) and Church & Dwight (CHD), However, rising input costs are a concern.
Why Is Clorox (CLX) Down 4.3% Since Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Company News for Nov 3, 2020
by Zacks Equity Research
Companies In The News Are: CLX, EL, NLSN, NCLH
Wall Street Waits for U.S. Presidential Election
by Zacks Equity Research
Wall Street Waits for U.S. Presidential Election
Clorox's (CLX) Q1 Earnings & Sales Surpass Estimates, Up Y/Y
by Zacks Equity Research
Clorox's (CLX) first-quarter fiscal 2021 results reflect gains from robust demand for disinfecting and cleaning products due to the coronavirus outbreak and broad-based growth at all segments.
Election Day: A Cure for Uncertainty?
by Mark Vickery
We start a new month in a more hopeful mood, after a rough October that lived up to its historical billing of the month most difficult to make money in equities.
Clorox (CLX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 37.61% and 9.12%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Things You Should Know About Clorox (CLX) Ahead of Q1 Earnings
by Zacks Equity Research
Clorox's (CLX) Q1 top line is likely to have gained from continued strong product demand and growth across segments. Higher costs and investments to meet demand are likely to have hurt margins.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $214.18, moving +0.68% from the previous trading session.
Clorox (CLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $211.35, marking a +0.35% move from the previous day.
Clorox (CLX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $218.37 in the latest trading session, marking a -0.26% move from the prior day.
Clorox (CLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $215.13, marking a +1.88% move from the previous day.
Coronavirus-Led Pet Boom Puts the Spotlight on These 7 Stocks
by Payel Dhar
As people are largely staying indoors due to the COVID-19 situation, they have taken to pets to fight emotional stress
Clorox (CLX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $210.17 in the latest trading session, marking a -0.11% move from the prior day.